Skip to Content
ProceedingsProceedings
  • Abstract
  • Open Access

25 February 2026

2 Pages

Development of a New Molecular Approach for Detecting Genetic Variants Predisposing to Thiopurine Toxicity in Pediatric ALL †

and
1
Department of Medical Sciences, University of Brasília (UNB), Brasília 70910-900, Brazil
2
Translational Research Laboratory, Hospital da Criança de Brasília José Alencar (HCB), Brasília 70684-831, Brazil
*
Author to whom correspondence should be addressed.
†
Presented at the 6th International Congress on Health Innovation—INOVATEC 2025, Hybrid, 21–23 November 2025.
Introduction: Thiopurine-associated toxicity in pediatric acute lymphoblastic leukemia (ALL) is related to polymorphisms in the TPMT and NUDT15 genes. Conventional screening techniques, such as allele-specific PCR, detect only recurrent variants, excluding rare ones of clinical relevance. Thus, this study proposes an alternative methodology based on Sanger sequencing of complementary DNA (cDNA), aiming to expand the detection of functional variants. Methodology: This was a retrospective and prospective longitudinal cohort study, in which samples from all patients diagnosed with B-ALL and treated at the Hospital da Criança de Brasília between 2024 and 2025 were included. RNA was extracted and converted into cDNA, followed by PCR with specific primers and sequencing of the TPMT and NUDT15 genes. The data were analyzed using bioinformatics software and classified according to the CPIC guidelines. The project was approved by the Research Ethics Committee (CAAE: 44796221.9.0000.0144). Results: Primers covering all exons of the TPMT and NUDT15 genes were synthesized and validated by PCR and 1.5% agarose gel electrophoresis. Ten samples have already been sequenced for the TPMT gene: two were classified as intermediate metabolizers, three as wild-type, and five carried the TPMT:c.474C>T variant, considered to have no impact on 6-mercaptopurine metabolism. Conclusions: Primer validation and preliminary sequencing results demonstrate the feasibility of the strategy. Sanger sequencing, widely used for diagnosing recurrent alterations in ALL, is also applicable for investigating variants associated with thiopurine toxicity. This study shows high potential but requires a larger cohort to corroborate the findings.

Author Contributions

Conceptualization, C.V.L. and A.C.M.S.J.; methodology, C.V.L. and A.C.M.S.J.; software, C.V.L. and A.C.M.S.J.; validation, C.V.L. and A.C.M.S.J.; formal analysis, C.V.L. and A.C.M.S.J.; investigation, C.V.L. and A.C.M.S.J.; resources, A.C.M.S.J.; data curation, C.V.L. and A.C.M.S.J.; writing—original draft preparation, C.V.L.; writing—review and editing, C.V.L. and A.C.M.S.J.; visualization, C.V.L. and A.C.M.S.J.; supervision, A.C.M.S.J.; project administration, A.C.M.S.J.; funding acquisition, A.C.M.S.J. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee (CAAE: 44796221.9.0000.0144, 4 July 2021).

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.